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IPD01:
METFORMIN IMPROVE UPPER TRACT UROTHELIAL CARCINOMA
SURVIVAL IN TAIWANESE PATIENTS WITH TYPE 2 DIABETES
Hsiang-Ying Lee 1,2, Ching-Chia Li 1,2, Hsin-Chih Yeh 1,2, Hung-Lung
Ke 1, Chun-Nung Huang 1, Wen-Jeng Wu1,2. 1Department of Urology,
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; 2Department of
Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
Purpose: The oral diabetes medicine metformin might have chemo-
preventive effects against cancer which was discussed before. However, no
clinical study exists for analyzing the effect of metformin in upper tract
urothelial carcinoma survival condition in type 2 diabetes patients which
presents an unusual feature in Taiwan. Therefore, we want to realize if
metformin can improve survival rate in upper tract urothelial carcinoma
patients through a population-based analysis.
Materials and Methods: The reimbursement databases of all Taiwanese
patients with a newly diagnosis of upper tract urothelial carcinoma be-
tween 2003 and 2011 (n ¼ 4418) were retrieved from the National Health
Insurance. Then we just extract type 2 diabetes mellitus patients with
more than two prescriptions diabetes mellitus drugs and delete only 1
prescription of metformin in prior 6 months (n ¼ 826). We calculate
hazard ratios by Cox regression for ever-users and never-users with SAS
statistical method.
Results: Among 826 enrolled patients, there are 358 patients never using
metformin and 468 ever take more than 2 prescription of metformin. 314
patients are male and 512 are female. The median survival time is 4.25
years for never using metformin and 6.97 years for ever-users and the
difference is signiﬁcant statistically. (P ¼ 0.0005) We also assess subgroup
of patients who received standard operation of nephroureterectomy and it
also revealed metformin have better survival rate.
Conclusion: This study suggests that metformin use is associated with
improving survival rate of upper tract urothelial carcinoma in patients
with T2DM.
IPD02:
LONG-TERM RESULT OF TOTAL URETERECTOMYWITH ILEAL-URETERAL
SUBSTITUTION IN THE TREATMENT OF URETERAL CANCER, A SINGLE-
CENTER EXPERIENCE
Yin-Chien Ou, Wen-Horng Yang. Department of Urology, National Cheng
Kung University Hospital, Tainan, Taiwan
Purpose: In the treatment of ureteral urothelial carcinoma, renal-sparing
procedures are of great importance for some well-selected patients.
However, these procedures may carry risks of under-staging and may not
be feasible in multifocal tumor. We performed total ureterectomy in order
to achieve maximal resection of the pathological ureter, and repaired the
ureteral defect with ileal-ureteral substitution.
Materials and Methods:We retrospectively reviewed the medical records
of all patients who underwent total ureterectomy with ileal-ureteral
substitution for ureteral urothelial carcinoma at our center from January
1988 through December 2015. Patient demographics, baseline renal
function, disease etiology, surgical procedures, pathology reports,perioperative and long-term complications, long-term renal function, and
the oncological outcome were recorded for analysis.
Results: A total of eight patients received total ureterectomy with ileal
ureteral substitution with a mean follow up period of 81.8 months. In-
dications included solitary kidney, chronic kidney disease, and bilateral
disease. The common perioperative complications were anastomotic urine
leakage and temporary hemodialysis, and the long-term complication was
mainly urinary tract infection. Preservation for renal functional was good,
with only one deteriorated patient that need life-long hemodialysis. Only
one patient (12.5%) experienced upper tract recurrence, and three patients
(37.5%) had bladder recurrence during follow up. The 5-year recurrence
free survival and cancer speciﬁc survival rate were 50% and 75%,
respectively.
Conclusion: Total ureterectomywith ileal ureteral substitution is a feasible
choice to treat ureteral UC when renal-sparing procedure is indicated. It
provides good long-term oncological outcome over upper tract, and also
preserves the renal function.
IPD03:
ASSOCIATION OF PREOPERATIVE PROTEINURIA WITH RENAL
FUNCTIONAL OUTCOMES AFTER OPEN PARTIAL NEPHRECTOMY IN
PATIENTS WITH AN ANATOMICALLY OR FUNCTIONALLY SOLITARY
KIDNEY
Hidekazu Tachibana, Toshio Takagi, Junpei Iizuka, Tsunenori Kondo, Hideki
Ishida, Kazunari Tanabe. Tokyo Women's Medical University, Department of
Urology, Japan
Purpose: Nephron-sparing surgery is required for patients with an
anatomically or functionally solitary kidney, for postoperative renal
function optimization. Open partial nephrectomy in the solitary kidney
is associated with reliable, long-term renal function, preventing pro-
gression to dialysis. Therefore, we aimed to identify the preoperative
factors associated with renal function decline after open partial
nephrectomy.
Materials and Methods: Patients who underwent open partial nephrec-
tomy for a renal tumor at our institution between 1986 and 2014,
excluding those who underwent ex vivo partial nephrectomy, were
retrospectively analyzed. Multivariate linear regression analysis was used
to test associations of a postoperative decrease in the estimated glomer-
ular ﬁltration rate (eGFR) with perioperative conditions such as the pre-
operative eGFR, preoperative proteinuria, tumor size, and intraoperative
renal ischemia time. Survival rates were analyzed using the Kaplan-Meier
method and log-rank statistics.
Results: In total, 83 patients were included in this study; 5 were excluded.
The median follow-up period for the remaining 78 patients was 34
months. The mean preoperative eGFR, tumor diameter, operative time,
renal ischemic time, and estimated blood loss were 51±14ml/min/1.73m2,
34±22 mm, 243±62 minutes, 41±22 minutes, and 355±333 ml, respec-
tively. In 18 patients (23%), the postoperative eGFR was <30 ml/min/
1.73 m2 12 months after surgery. Only 1 patient needed chronic hemodi-
alysis 12 months after surgery. On multivariate analysis, preoperative
proteinuria (odds ratio [OR] 8.7, 95% conﬁdence interval [CI] 1.6e58.8,
P¼0.01) and eGFR (OR 0.83, 95% CI 0.74e0.91, P¼0.001) were signiﬁcant
predictors of a decrease in eGFR to <30 ml/min/1.73 m2 after surgery. The
probability of freedom from eGFR <30 ml/min/1.73 m2 after 24 months
Abstracts / Urological Science 27 (2016) S24eS35 S25was higher in patients without preoperative proteinuria (76% vs. 94%,
P¼0.0027).
Conclusion: Preoperative proteinuria could help stratify patients accord-
ing to the risk of renal function exacerbation.
IPD04:
TUMOR CONTACT SURFACE AREA IS ASSOCIATED WITH VOLUME LOSS
AND FUNCTIONAL DECLINE AFTER PARTIAL NEPHRECTOMY
Yu-De Wang, Chao-Hsiang Chang, Chi-Ping Huang, Hsi-Chin Wu, Che-Rei
Yang, Guang-Heng Chen, Po-Fan Hsieh. Department of Urology, China
Medical University Hospital, Taichung, Taiwan
Purpose: We propose a formula of calculate-based contact surface area
(CSA). We examined the correlation of contact surface area and renal
volume loss and the predictability for renal function after partial
nephrectomy.
Materials and Methods: We conducted a retrospective study in patients
who underwent partial nephrectomy between January 2012 and
December 2014. Based on abdominopelvic CT and MRI, we calculated the
contact surface areawith the formula “2* p *Radius*Depth”; while resected
and ischemic volume (RAIV) was determined by the equation”
[2w^2+3w(r+d)+6rd]*w*p)/3”. We evaluated the correlation between CSA,
RAIV and perioperative parameters. And we comparatively analyzed the
ability of CSA and RAIV to predict the reduction in renal function.
Results: There were 35, 26, and 45 patients receiving OPN, LPN, RPN
respectively. The mean±SD contact surface area was 30.7±26.1 cm2, and
and the mean±SD RAIV was 19.1±14.4 cm3. On Spearman correlation
analysis we found that CSA and RAIV were highly correlated (coefﬁcient:
0.99, p<0.001). In univariate analysis, BMI (p¼0.02), EBL (p¼0.001), RAIV
(p<0.001), and CSA (p<0.001) signiﬁcantly affected postoperative renal
function. In ROC curve analysis, both CSA and RAIV have good ability to
predict more than 10% change of estimated glomerular ﬁltration rate (AUC:
0.86 vs. 0.87). There is no signiﬁcant difference in AUC between CSA and
RAIV. The area difference in PCE10 was 0.002 (p¼0.51)
Conclusion: In our study, CSA and RAIV were correlated with several
perioperative outcomes and affected post-operative renal function. The
ability to predict post-operative renal function between CSA and RAIV was
nearly identical. Since CSA was simpler to use, and may possess less
interobserver variability in comparisonwith RAIV, we believe that CSA can
represent renal parenchymal loss.
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IPD05:
CHARACTERISTICS OF EARLY-ONSET HEMATOTOXICITY OF SUNITINIB
IN JAPANESE PATIENTS WITH RENAL CELL CARCINOMA
Renpei Kato, Yoichiro Kato, Tomohiko Matsuura, Mitsugu Kanehira, Ryo
Takata, Wataru Obara. Department of Urology, Iwate Medical University
School of Medicine, Morioka, Japan
Purpose: To identify the characteristics of early-onset hematotoxicity of
sunitinib in Japanese renal cell carcinoma (RCC) patients.
Material and Methods: Seventy-nine patients were treated with sunitinib
as 6-week cycles of “4-week on 2-week off” schedule. To evaluate early-
onset hematotoxicity, we compared patients with dose reduction during
the ﬁrst cycle (dose-reduced group, n¼57) and those who maintained the
initial dose (dose-maintained group, n¼22). ABCG2 and ﬂt-3 genotypes
were analyzed for association between hematotoxicity and reported gene
polymorphisms.
Results: Mean relative dose intensity (RDI) was similar in two groups
during the ﬁrst two weeks of dosing in the ﬁrst cycle, but was signiﬁcantly
lower in dose-reduced group during the last twoweeks. Lymphocytopenia,
thrombocytopenia, and increased aspartate aminotransferase were
observed in dose-reduced group within the ﬁrst two weeks. Genetic
analysis indicated signiﬁcantly higher frequency of ﬂt-3 738T/C poly-
morphism in dose-reduced group, but no signiﬁcant difference in ABCG2
421C/A polymorphism.Conclusion: This study showed a high incidence of sunitinib-induced
hematotoxicity in Japanese RCC patients, many of whom need dose
adjustment during the ﬁrst cycle. Further studies should verify whether
dose adjustment based on early-onset thrombocytopenia prolongs suni-
tinib treatment.
IPD06:
USE OF INTRAOPERATIVE STRAIN ELASTOGRAPHY OF SMALL RENAL
MASSES TO DIFFERENTIATE BETWEEN ANGIOMYOLIPOMA AND
RENAL CELL CARCINOMA
Shohei Fukuda, Toshihiro Kanda, Naotaka Fukui, Yukio
Kageyama. Department of Urology, Saitama Cancer Center, Saitama, Japan
Purpose: Elastography is a novel ultrasound modality that evaluates tissue
stiffness. This modality has been applied for the preoperative diagnosis of
breast, liver, prostate, kidney, and thyroid cancers. In this study we
assessed the diagnostic value of intraoperative elastography in patients
with renal tumors.
Materials and Methods: This prospective study included 46 patients
(mean age 62.4 years; range 38e85 years) with a renal tumor or tumors
who underwent partial or radical nephrectomy fromMay 2014 to February
2016. Strain elastography was performed intraoperatively and strain ratios
(tumor versus normal parenchyma) were evaluated before renal artery
dissection in 46 renal tumors (mean size 41.5 mm; range 9.0e127 mm).
Histology of the resected tumors revealed clear cell renal cell carcinoma
(RCC) in 32, chromophobe RCC in 3, papillary RCC in 1, multilocular cystic
RCC in 1, invasive urothelial carcinoma (UC) in 1, oncocytoma in 1, angio-
myolipoma (AML) in 6 and leiomyoma in 1.
Results: The median tumor diameters were 41 mm (range 12e80 mm) for
clear cell RCC, 25 mm (range 18e52 mm) for chromophobe RCC, 39 mm
for papillary RCC, 18 mm for multilocular cystic RCC, 66 mm for invasive
UC, 17mm for oncocytoma, 13.5 mm (range 9.0e127 mm) for AML, and
79 mm for leiomyoma. The median strain ratios were 1.67 (range
0.37e4.75) for clear cell RCC, 1.30 (range 0.81e2.52) for chromophobe
RCC, 4.11 for papillary RCC, 2.29 for multilocular cystic RCC, 6.00 for
invasive UC, 1.85 for oncocytoma, 1.13 (range 0.30e2.29) for AML, and 1.68
for leiomyoma. For tumors smaller than 40 mm, the median strain ratio
was signiﬁcantly higher in RCCs (clear cell, chromophobe, papillary, and
multilocular cystic; n¼20) compared with AMLs (n¼5) (2.09 [range
0.37e4.11] versus 1.11 [range 0.30e1.18]) (p¼0.010). According to receiver
operating characteristic curve analysis, the optimal cut-off value for dis-
tinguishing between RCCs and AML was 1.29, with a sensitivity and
speciﬁcity of 85% and 100%, respectively. The area under the curve was
0.880.
Conclusion: Intraoperative strain elastography may be a useful modality
for differentiating between AML and RCCs in patients with renal masses
smaller than 40 mm.
IPD07:
BIOPSY FOLLOW-UP IN PATIENTS WITH ATYPICAL SMALL ACINAR
PROLIFERATION AND PROSTATE INTRAEPITHELIAL NEOPLASM IN
PROSTATE BIOPSY
Sheng-Yung Tung, Chung-Hsin Chen, Huai-Chin Tai, Sho-Mon Wang, Kuo-
How Huang, Chao-Yuan Huang, Shih-Ping Liu, Yeong-Shiau
Pu. Department of Urology, National Taiwan University Hospital, Taipei,
Taiwan
Purpose: We investigated the prognosis and outcome of atypical small
acinar proliferation (ASAP) and extensive high grade prostate intra-
epithelial neoplasm (PIN) in prostate cancer detection in Taiwan.
Materials and Methods:We retrospectively reviewed our prostate biopsy
database containing data acquired over a 20-year period in National
Taiwan University Hospital. Data collection was done by chart review. We
analyzed patient in this study period with pathology reports including
atypical glands, atypical small acinar proliferation, prostatic intraepithelial
neoplasia after receiving prostate biopsy.
Results: A total of 66 patients were enrolled. 38 patients initially had
atypical glands/ atypical small acinar proliferation; 26 patients initially
had prostatic intraepithelial neoplasia; and 2 patient had atypical small
